1. Home
  2. LTRN vs MDCX Comparison

LTRN vs MDCX Comparison

Compare LTRN & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LTRN
  • MDCX
  • Stock Information
  • Founded
  • LTRN 2013
  • MDCX 2008
  • Country
  • LTRN United States
  • MDCX Canada
  • Employees
  • LTRN N/A
  • MDCX N/A
  • Industry
  • LTRN Biotechnology: Pharmaceutical Preparations
  • MDCX
  • Sector
  • LTRN Health Care
  • MDCX
  • Exchange
  • LTRN Nasdaq
  • MDCX Nasdaq
  • Market Cap
  • LTRN 33.7M
  • MDCX 33.8M
  • IPO Year
  • LTRN 2020
  • MDCX N/A
  • Fundamental
  • Price
  • LTRN $5.08
  • MDCX $2.83
  • Analyst Decision
  • LTRN Hold
  • MDCX Strong Buy
  • Analyst Count
  • LTRN 1
  • MDCX 1
  • Target Price
  • LTRN N/A
  • MDCX $10.00
  • AVG Volume (30 Days)
  • LTRN 155.4K
  • MDCX 9.0K
  • Earning Date
  • LTRN 03-17-2025
  • MDCX 01-01-0001
  • Dividend Yield
  • LTRN N/A
  • MDCX N/A
  • EPS Growth
  • LTRN N/A
  • MDCX N/A
  • EPS
  • LTRN N/A
  • MDCX N/A
  • Revenue
  • LTRN N/A
  • MDCX N/A
  • Revenue This Year
  • LTRN N/A
  • MDCX N/A
  • Revenue Next Year
  • LTRN N/A
  • MDCX N/A
  • P/E Ratio
  • LTRN N/A
  • MDCX N/A
  • Revenue Growth
  • LTRN N/A
  • MDCX N/A
  • 52 Week Low
  • LTRN $2.79
  • MDCX $1.80
  • 52 Week High
  • LTRN $11.99
  • MDCX $3.23
  • Technical
  • Relative Strength Index (RSI)
  • LTRN 64.21
  • MDCX N/A
  • Support Level
  • LTRN $4.60
  • MDCX N/A
  • Resistance Level
  • LTRN $5.30
  • MDCX N/A
  • Average True Range (ATR)
  • LTRN 0.61
  • MDCX 0.00
  • MACD
  • LTRN 0.06
  • MDCX 0.00
  • Stochastic Oscillator
  • LTRN 68.99
  • MDCX 0.00

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.

About MDCX Medicus Pharma Ltd. Common Stock

Medicus Pharma Ltd is a clinical-stage, multi-strategy holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA approved clinical trials.

Share on Social Networks: